Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOLD-EXT long-term extension study of odevixibat in children with biliary atresia
CTR20233090Phase 3Terminated
- Sponsor
- Albireo Pharma
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of odevixibat in biliary atresia, sponsored by Albireo Pharma. Started Mar 2024; status: terminated.
02
Drugs
odevixibat
03
Conditions
biliary atresia
Beyond the preview
Go deeper on CTR20233090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233090.